559 related articles for article (PubMed ID: 24870443)
21. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
Engler H; Forsberg A; Almkvist O; Blomquist G; Larsson E; Savitcheva I; Wall A; Ringheim A; Långström B; Nordberg A
Brain; 2006 Nov; 129(Pt 11):2856-66. PubMed ID: 16854944
[TBL] [Abstract][Full Text] [Related]
22. In vivo molecular neuroimaging of glucose utilization and its association with fibrillar amyloid-β load in aged APPPS1-21 mice.
Waldron AM; Wintmolders C; Bottelbergs A; Kelley JB; Schmidt ME; Stroobants S; Langlois X; Staelens S
Alzheimers Res Ther; 2015 Dec; 7(1):76. PubMed ID: 26666747
[TBL] [Abstract][Full Text] [Related]
23. Regional brain hypometabolism is unrelated to regional amyloid plaque burden.
Altmann A; Ng B; Landau SM; Jagust WJ; Greicius MD;
Brain; 2015 Dec; 138(Pt 12):3734-46. PubMed ID: 26419799
[TBL] [Abstract][Full Text] [Related]
24. Asymmetries of amyloid-β burden and neuronal dysfunction are positively correlated in Alzheimer's disease.
Frings L; Hellwig S; Spehl TS; Bormann T; Buchert R; Vach W; Minkova L; Heimbach B; Klöppel S; Meyer PT
Brain; 2015 Oct; 138(Pt 10):3089-99. PubMed ID: 26280595
[TBL] [Abstract][Full Text] [Related]
25. Imaging in-vivo tau pathology in Alzheimer's disease with THK5317 PET in a multimodal paradigm.
Chiotis K; Saint-Aubert L; Savitcheva I; Jelic V; Andersen P; Jonasson M; Eriksson J; Lubberink M; Almkvist O; Wall A; Antoni G; Nordberg A
Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1686-99. PubMed ID: 26996778
[TBL] [Abstract][Full Text] [Related]
26. Reproducibility of automated simplified voxel-based analysis of PET amyloid ligand [11C]PIB uptake using 30-min scanning data.
Aalto S; Scheinin NM; Kemppainen NM; Någren K; Kailajärvi M; Leinonen M; Scheinin M; Rinne JO
Eur J Nucl Med Mol Imaging; 2009 Oct; 36(10):1651-60. PubMed ID: 19495749
[TBL] [Abstract][Full Text] [Related]
27. White matter lesion load is associated with resting state functional MRI activity and amyloid PET but not FDG in mild cognitive impairment and early Alzheimer's disease patients.
Zhou Y; Yu F; Duong TQ;
J Magn Reson Imaging; 2015 Jan; 41(1):102-9. PubMed ID: 24382798
[TBL] [Abstract][Full Text] [Related]
28. Diabetes and elevated hemoglobin A1c levels are associated with brain hypometabolism but not amyloid accumulation.
Roberts RO; Knopman DS; Cha RH; Mielke MM; Pankratz VS; Boeve BF; Kantarci K; Geda YE; Jack CR; Petersen RC; Lowe VJ
J Nucl Med; 2014 May; 55(5):759-64. PubMed ID: 24652830
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of voxel-based methods for the statistical analysis of PIB PET amyloid imaging studies in Alzheimer's disease.
Ziolko SK; Weissfeld LA; Klunk WE; Mathis CA; Hoge JA; Lopresti BJ; DeKosky ST; Price JC
Neuroimage; 2006 Oct; 33(1):94-102. PubMed ID: 16905334
[TBL] [Abstract][Full Text] [Related]
30. Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease.
Lehmann M; Ghosh PM; Madison C; Laforce R; Corbetta-Rastelli C; Weiner MW; Greicius MD; Seeley WW; Gorno-Tempini ML; Rosen HJ; Miller BL; Jagust WJ; Rabinovici GD
Brain; 2013 Mar; 136(Pt 3):844-58. PubMed ID: 23358601
[TBL] [Abstract][Full Text] [Related]
31. Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease.
Chételat G; Desgranges B; Landeau B; Mézenge F; Poline JB; de la Sayette V; Viader F; Eustache F; Baron JC
Brain; 2008 Jan; 131(Pt 1):60-71. PubMed ID: 18063588
[TBL] [Abstract][Full Text] [Related]
32. Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.
Okamura N; Furumoto S; Fodero-Tavoletti MT; Mulligan RS; Harada R; Yates P; Pejoska S; Kudo Y; Masters CL; Yanai K; Rowe CC; Villemagne VL
Brain; 2014 Jun; 137(Pt 6):1762-71. PubMed ID: 24681664
[TBL] [Abstract][Full Text] [Related]
33. Cerebral Amyloid Angiopathy-Related Microbleeds Correlate with Glucose Metabolism and Brain Volume in Alzheimer's Disease.
Samuraki M; Matsunari I; Yoshita M; Shima K; Noguchi-Shinohara M; Hamaguchi T; Ono K; Yamada M
J Alzheimers Dis; 2015; 48(2):517-28. PubMed ID: 26402015
[TBL] [Abstract][Full Text] [Related]
34. The effect of amyloid pathology and glucose metabolism on cortical volume loss over time in Alzheimer's disease.
Adriaanse SM; van Dijk KR; Ossenkoppele R; Reuter M; Tolboom N; Zwan MD; Yaqub M; Boellaard R; Windhorst AD; van der Flier WM; Scheltens P; Lammertsma AA; Barkhof F; van Berckel BN
Eur J Nucl Med Mol Imaging; 2014 Jun; 41(6):1190-8. PubMed ID: 24615466
[TBL] [Abstract][Full Text] [Related]
35. Amyloid load and cerebral atrophy in Alzheimer's disease: an 11C-PIB positron emission tomography study.
Archer HA; Edison P; Brooks DJ; Barnes J; Frost C; Yeatman T; Fox NC; Rossor MN
Ann Neurol; 2006 Jul; 60(1):145-7. PubMed ID: 16802294
[TBL] [Abstract][Full Text] [Related]
36. FDG-PET Patterns Predict Amyloid Deposition and Clinical Profile in Corticobasal Syndrome.
Parmera JB; Coutinho AM; Aranha MR; Studart-Neto A; de Godoi Carneiro C; de Almeida IJ; Fontoura Solla DJ; Ono CR; Barbosa ER; Nitrini R; Buchpiguel CA; Brucki SMD
Mov Disord; 2021 Mar; 36(3):651-661. PubMed ID: 33206389
[TBL] [Abstract][Full Text] [Related]
37. Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.
Ishii K; Willoch F; Minoshima S; Drzezga A; Ficaro EP; Cross DJ; Kuhl DE; Schwaiger M
J Nucl Med; 2001 Apr; 42(4):548-57. PubMed ID: 11337540
[TBL] [Abstract][Full Text] [Related]
38. Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia.
Trzepacz PT; Yu P; Sun J; Schuh K; Case M; Witte MM; Hochstetler H; Hake A;
Neurobiol Aging; 2014 Jan; 35(1):143-51. PubMed ID: 23954175
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Early-Phase 11C-Deuterium-l-Deprenyl and 11C-Pittsburgh Compound B PET for Assessing Brain Perfusion in Alzheimer Disease.
Rodriguez-Vieitez E; Carter SF; Chiotis K; Saint-Aubert L; Leuzy A; Schöll M; Almkvist O; Wall A; Långström B; Nordberg A
J Nucl Med; 2016 Jul; 57(7):1071-7. PubMed ID: 26912447
[TBL] [Abstract][Full Text] [Related]
40. Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls.
Scheinin NM; Aalto S; Koikkalainen J; Lötjönen J; Karrasch M; Kemppainen N; Viitanen M; Någren K; Helin S; Scheinin M; Rinne JO
Neurology; 2009 Oct; 73(15):1186-92. PubMed ID: 19726751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
